Hydrotherapy CP and Lying Down to Sitting Position

NCT ID: NCT05091892

Last Updated: 2022-11-03

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 40 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-09-01
• Study Completion Date: 2022-03-30

Brief Summary

The purpose of this study is to investigate the effect of a very specific hydrotherapy programm on the movement from lying down to sitting position for children with CP

Detailed Description

40 children aged 5-11 years with cerebral palsy and difficulty in the transfer activity from lying down to sitting position were randomly divided into 2 groups of 20 children, a land group and a water group. The children of the land attended a neurodevelopmental treatment program and the water group a very specific program in hydrotherapy on combined rotation at all levels. The water program was implemented by specialized physiotherapists in hydrotherapy. The duration of the program for both groups was 3 months. On the first and last day of the intervention, an evaluation of all children was performed using the GMFM and PBS evaluation tests of the evaluation parameters of the transfer from the lying position to the sitting position.

Conditions

Cerebral Palsy

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: DOUBLE

Study Groups

Water Group

Neurodevelopmental treatment

Group Type: EXPERIMENTAL

Hydrotherapy programm

Intervention Type: OTHER

Treatment

Land Group

Lonqitudinal, transversal and compined rotation in a hydrotherapy programm

Group Type: EXPERIMENTAL

Hydrotherapy programm

Intervention Type: OTHER

Treatment

Interventions

Hydrotherapy programm

Treatment

Intervention Type: OTHER

Other Intervention Names

Neurodevelomental treatment

Eligibility Criteria

Inclusion Criteria

• Cerebral palsy
• DIfficulties from lying down to sitting posistion

Exclusion Criteria

• Surgery or injection of botilium toxin in the last year.
• Scheduled surgery or injection of botilium toxin.
• Uncontrolled seizures.
• Do not run elementary commands or play a test representation.
• Autism.
• Syndromes without OP.
• Serious vision problem.
• Absence from the treatment program for more than a week.

• Minimum Eligible Age: 5 Years
• Maximum Eligible Age: 11 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Thessaly

OTHER

Sponsor Role: lead

Responsible Party

Konstantinos Chandolias

Dr Konstantinos Chandolias

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Konstantinos Chandolias

Thessaloniki, , Greece

Countries

Greece

Other Identifiers

KC140180

Identifier Type: -

Identifier Source: org_study_id